Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease

Nicotinamide adenine dinucleotide (NAD(+)) repletion has been shown to provide marked neuroprotection from genotoxic agent-induced neuronal and astrocyte cell death. One of the key precursors of NAD(+) is nicotinamide mononucleotide (NMN). Therefore, it was hypothesized that NMN may attenuate apopto...

Descripción completa

Detalles Bibliográficos
Autores principales: LU, LEI, TANG, LE, WEI, WENSHI, HONG, YUNYI, CHEN, HEYU, YING, WEIHAI, CHEN, SHENGDI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113526/
https://www.ncbi.nlm.nih.gov/pubmed/25120628
http://dx.doi.org/10.3892/etm.2014.1842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113526/
https://www.ncbi.nlm.nih.gov/pubmed/25120628
http://dx.doi.org/10.3892/etm.2014.1842

Ejemplares similares